The embattled German agricultural conglomerate BayWa is navigating a perfect storm of legal threats, governance breakdowns, and a precarious financial restructuring. The company’s survival plan is under severe strain, with creditors holding decisive power and a wave of shareholder lawsuits now imminent.
A formal reprimand from German financial watchdog BaFin has provided fresh ammunition for investors. The regulator found that BayWa’s 2023 management report omitted critical details, specifically concerning a billion-euro loan and refinancing risks tied to a €500 million bond. Law firm TILP is preparing damages claims for affected shareholders based on this finding. In a parallel development, Munich prosecutors have opened an investigation into former CEO Marcus Pöllinger on suspicion of breach of trust.
Governance is crumbling on multiple fronts. BayWa is losing three supervisory board members: Monika Hohlmeier and Michael Höllerer left at the end of March, with Monique Surges to follow at the close of May. No successors have been named. The remaining board has responded to past control deficits by slashing the approval threshold for transactions from €200 million to €50 million. Over at the energy subsidiary BayWa r.e., three representatives from the 49% investor Energy Infrastructure Partners have resigned their mandates, leaving EIP with just one board seat to BayWa AG’s four.
The exit of auditor PricewaterhouseCoopers adds another layer of complexity. PwC is departing because it failed to flag existential risks in the 2023 group accounts. The audit mandate for 2026 has been put out to tender, and BaFin’s audit oversight body, Apas, has initiated professional disciplinary proceedings. BayWa’s management is also examining potential liability claims against the auditor. For the transition, PwC will still review the delayed 2025 group financials, which are not expected until the fourth quarter of 2026, leaving investors without reliable data for the foreseeable future.
Should investors sell immediately? Or is it worth buying BayWa?
Financially, the gap is staggering. The restructuring requires €4 billion by 2028, but a €2.7 billion shortfall remains. The collapse of the planned sale of BayWa r.e. in early 2025 has intensified pressure on the remaining asset disposals. By the end of April, the group expects €45 million from the sale of Cefetra, supplemented by roughly €62 million from repaid shareholder loans. This move will also reduce group bank debt by over €600 million.
The next critical piece is the sale of the 74% stake in T&G Global, a process guided by Goldman Sachs. The profitable subsidiary, known for apple brands like Envy and Jazz, could fetch around €300 million, though the process is reportedly being slowed by a minority Asian shareholder. Analysts view even a successful sale as a drop in the ocean relative to the funding gap. Management has responded by completely withdrawing its 2026 forecast and lowering its adjusted EBITDA target for 2027 to approximately €140 million, linked to the elimination of 1,300 jobs.
Ultimately, the fate of the entire restructuring rests with core lenders DZ Bank and HVB. They must agree to extend a standstill agreement until autumn 2026. Without this formal creditor approval, the insolvency plan loses its legal foundation. Some creditors are already cutting their losses; Bavarian cooperative banks have written off 60% of a multi-million-euro loan.
This profound uncertainty is reflected in the share price, which currently trades at €13.20, marking a year-to-date loss exceeding 21%. The stock remains well below its 200-day moving average of €17.07. With audited accounts delayed and creditors at the helm, BayWa’s ambitious goal to shrink revenue to €10 billion by 2028 faces its most critical test in the coming months.
Ad
BayWa Stock: Buy or Sell?! New BayWa Analysis from April 14 delivers the answer:
The latest BayWa figures speak for themselves: Urgent action needed for BayWa investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 14.
BayWa: Buy or sell? Read more here...
